Evidence map›Paper›PMID 37350196›Full record

ArticleClinical and translational science2023

Longitudinal estimated glomerular filtration rate (eGFR) modeling in long-term renal function to inform clinical trial design in kidney transplantation.

Luke Kosinski, Eric Frey, Amanda Klein, Inish O'Doherty, Klaus Romero, Mark Stegall, Ilkka Helanterä, Ahmed Osama Gaber, William E Fitzsimmons, Varun Aggarwal and 1 more

Abstract read
In one paragraph

Article in Clinical and translational science, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Luke KosinskiCritical Path Institute, Tucson, Arizona, USA.ORCID 0000-0002-8146-5955
Eric FreyCritical Path Institute, Tucson, Arizona, USA.
Amanda KleinCritical Path Institute, Tucson, Arizona, USA.ORCID 0000-0002-4588-9224
Inish O'DohertyCritical Path Institute, Tucson, Arizona, USA.ORCID 0000-0001-9958-5333
Klaus RomeroCritical Path Institute, Tucson, Arizona, USA.ORCID 0000-0002-8576-8638
Mark StegallDepartment of Surgery, Mayo Clinic, Rochester, Minnesota, USA.ORCID 0000-0002-1392-0792
Ilkka HelanteräDepartment of Transplantation and Liver Surgery, Helsinki University Hospital, Helsinki, Finland.ORCID 0000-0002-2954-2538
Ahmed Osama GaberDepartment of Surgery, Houston Methodist Hospital, Houston, Texas, USA.ORCID 0000-0002-0743-4974
William E FitzsimmonsCritical Path Institute, Tucson, Arizona, USA.ORCID 0000-0002-6189-5499
Varun AggarwalCritical Path Institute, Tucson, Arizona, USA.ORCID 0000-0002-8406-0961
Transplant Therapeutics Consortium (TTC)

Funding

FDA HHS HHSF223201810114CFDA HHS U18 FD005320
6 · The paper itself

Abstract

Kidney transplantation is the preferred treatment for individuals with end-stage kidney disease. From a modeling perspective, our understanding of kidney function trajectories after transplantation remains limited. Current modeling of kidney function post-transplantation is focused on linear slopes or percent decline and often excludes the highly variable early timepoints post-transplantation, where kidney function recovers and then stabilizes. Using estimated glomerular filtration rate (eGFR), a well-known biomarker of kidney function, from an aggregated dataset of 4904 kidney transplant patients including both observational studies and clinical trials, we developed a longitudinal model of kidney function trajectories from time of transplant to 6 years post-transplant. Our model is a nonlinear, mixed-effects model built in NONMEM that captured both the recovery phase after kidney transplantation, where the graft recovers function, and the long-term phase of stabilization and slow decline. Model fit was assessed using diagnostic plots and individual fits. Model performance, assessed via visual predictive checks, suggests accurate model predictions of eGFR at the median and lower 95% quantiles of eGFR, ranges which are of critical clinical importance for assessing loss of kidney function. Various clinically relevant covariates were also explored and found to improve the model. For example, transplant recipients of deceased donors recover function more slowly after transplantation and calcineurin inhibitor use promotes faster long-term decay. Our work provides a generalizable, nonlinear model of kidney allograft function that will be useful for estimating eGFR up to 6 years post-transplant in various clinically relevant populations.

Indexed as

Kidney Failure, ChronicKidney TransplantationClinical Trials as TopicGlomerular Filtration RateHumansKidney

Identifiers

PMID37350196
PMCPMC10499426

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.